CJC-1295 with Ipamorelin 10MG vial
Athletic Performance

CJC-1295 with Ipamorelin 10mg

CAS 863288-34-0 / 170851-70-4 · Blended lyophilized powder, sealed vial

Two mechanisms in one vial: the pairing GH-axis researchers reach for first. Lot-verified, ≥99% pure.

$89.00

Quantity

1
  • ≥99% purity, confirmed by third-party HPLC and MS on every lot
  • Lot-matched COA tested by ACS Laboratory, Florida
  • USA manufactured, cold-chain packed end to end
  • Lyophilized and sealed for stable transit and long shelf life
  • Same-day dispatch from Miami on orders placed before cut-off

Research-grade. For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.

Free shipping over $300 HPLC/MS tested Secure payment

What it is

A blended preparation of CJC-1295 (a modified GHRH analog) and ipamorelin (a selective ghrelin-receptor secretagogue). The two act on separate receptors, which is why they are studied together rather than in place of one another.

Studied in research for its role in

  • Combined GHRH and ghrelin-receptor stimulation
  • Endogenous GH pulse amplitude and frequency
  • IGF-1 axis response research
  • Comparative single- versus dual-pathway secretagogue studies

Specifications

Compound
CJC-1295 (no DAC) + Ipamorelin
CAS
863288-34-0 / 170851-70-4
Form
Blended lyophilized powder, sealed vial
Sizes
10MG
Purity
≥99% (HPLC/MS)
Storage
Cool, dry, out of light